Examining the relationship between beverage intake and cardiovascular health. Ian Macdonald University of Nottingham UK

Similar documents
Flavonoids and Cardiovascular Disease

JoAnn E. Manson, MD, DrPH Howard D. Sesso, ScD, MPH Brigham and Women's Hospital Harvard Medical School

Flavonoids and their contribution to health: a look at the scientific support

Antioxidants in food, drinks and supplements for cardiovascular health

THE SAME EFFECT WAS NOT FOUND WITH SPIRITS 3-5 DRINKS OF SPIRITS PER DAY WAS ASSOCIATED WITH INCREASED MORTALITY

Heart Disease Genesis

The COSMOS Trial. (COcoa Supplement and Multivitamins Outcomes Study) JoAnn E. Manson, MD, DrPH Howard D. Sesso, ScD, MPH

A Proposed Randomized Trial of Cocoa Flavanols and Multivitamins in the Prevention of Cardiovascular Disease and Cancer

Metabolic Factors Frequency of Chocolate Consumption and Body Mass Index

Dairy consumption and cardiometabolic health do the trials support the epidemiology?

Traditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( )

Sugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA

Total risk management of Cardiovascular diseases Nobuhiro Yamada

ICPH 2013 Buenos Aires, Argentina October 19 th, 2013

The impact of dairy products on cardiovascular health

Nutrients and Circulatory Function

Cardiovascular Outcome

Cocoa beans as the starting ingredients in manufacturing dark chocolate

Consumption of different types of alcohol and mortality

Overview of effects of alcohol intake on cardiovascular disease

SFRBM Annual Meeting, Pre-meeting Workshop II Flavanols in Health and Disease

Cocoa in cardiovascular medicine. Remedy or hype?

Proven and Proposed Cardiovascular Benefits of Soyfoods

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION

Tea Expert Newsletter Issue five. Scientific update on tea, flavonoids and blood pressure

Ketogenic Diets-good, bad, indifferent? Peter Clifton CSIRO Human Nutrition

Dyslipidemia in women: Who should be treated and how?

Clinical Recommendations: Patients with Periodontitis

Update in Hypertension

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

Diabetes Mellitus: A Cardiovascular Disease

Chocolate, red wine, peanuts health foods or indulgences? Alison Coates, PhD, RNutr

Gemma Cooper University of Nottingham

Cardiovascular Risk Assessment and Management Making a Difference

ASSeSSing the risk of fatal cardiovascular disease

Blood Pressure Acre Surgery Diviash Thakrar

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Risk Factors for NCDs

Cardiovascular health benefits of plant-based eating

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Lipid Management 2013 Statin Benefit Groups

Put your Heart before your Head

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Fructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism

Low carbohydrate diets- do they have a place?

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

OUR MISSION: DELIVERING THE PROOF OF THE

Exploring the links between Food, Diet and Non-Communicable Disease

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

The Mediterranean Diet: The Optimal Diet for Cardiovascular Health

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Clinical Care Performance. Financial Year 2012 to 2018

Overview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures

T. Suithichaiyakul Cardiomed Chula

The Clinical Unmet need in the patient with Diabetes and ACS

WHICH DIET FOR THE PREVENTION OF CARDIOVASCULAR DISEASE MEAT OR VEGETARISM

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Cho et al., 2009 Journal of Cardiology (2009), 54:

Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016

Patient is healthy with no chronic disease or significant risk factors [16%].

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Should we base treatment decisions on short-term or lifetime CVD risk? Rod Jackson University of Auckland New Zealand

Dairy matrix effects on T2 diabetes and cardiometabolic health?

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

Cardiovascular System and Health. Chapter 15

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

L III: DIETARY APPROACH

Report Operation Heart to Heart

No relevant financial relationships

Using Scientific Nutrition Research to Reach Millennial Consumers

Saturated fat- how long can you go/how low should you go?

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart

The Diabetes Link to Heart Disease

Cardiovascular Complications of Diabetes

Long-Term Complications of Diabetes Mellitus Macrovascular Complication

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Cardiovascular risk potential of dietary saturated fats: an update and some implications

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Managing HTN in the Elderly: How Low to Go

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Your Name & Phone Number Here! Longevity Index

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s

Estrogens vs Testosterone for cardiovascular health and longevity

Results/ conclusion. Reference Duration Number subjects. Study description. Limitations of the data. Randomized controlled trial (RCT)

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies

Heart Health. Team Member Workbook Session 1 LEARN IDENTIFY ACT. Learn about HTHU Level 3 and the point system

Fructose, Uric Acid and Hypertension in Children and Adolescents

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Title:Dark chocolate and reduced snack consumption in mildly hypertensive adults: an intervention study

Disclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Identification of subjects at high risk for cardiovascular disease

Transcription:

Examining the relationship between beverage intake and cardiovascular health Ian Macdonald University of Nottingham UK

Outline Assessment of evidence in relation to health risks of dietary components Cardiovascular health/disease Tea Cocoa Milk Red wine

Assessment of evidence in diet/nutrition studies Types of studies: cross-sectional epidemiology, cohort studies, randomised controlled trials Systematic review with or without meta-analysis Outcome variables: events or risk factors/markers Limitations of studies Cross-sectional epidemiology: associations, no links to causality or time-trends Cohort studies: confounding from other lifestyle factors. For CVD/metabolic outcomes need to control for smoking, alcohol, BMI, gender, physical activity If looking at dietary macronutrients, what changes/differences exist (eg if CHO goes down what goes up)? RCTs often do not achieve a long term magnitude of change which is intended (eg WHI increase fruit & vegetable intake)

Cardiovascular health Tea Peters et al (2001) - tea associated with reduced CVD risk (although 3 studies showed increased risk) Arab et al (2009) - meta-analysis of green and black tea and stroke >3 cups a day reduced stroke risk by 21% (no difference between black or green tea) Wang et al (2011) - meta-analysis of links between tea and coronary artery disease (CAD). 13 on black tea (USA and Europe) 5 on green tea (China and Japan). No significant association was found between black tea consumption and CAD. Green tea associated with reduced risk of CAD (10% decrease for 1 cup/day). (Ethnic / regional confounding?)

Arab et al Stroke reduction

Wang et al, Black tea and CAD

Wang et al, Green tea and CAD Geleijnse et al (1999) - Rotterdam Heart study, clinically diagnosed atherosclerosis and tea intake - Significant negative association. Relative risk was 1 for <125ml/d, 0.54 for 125-250ml/d, 0.31 for >500ml/d

Tea: CV health markers BP no apparent effect of tea on BP. Acute consumption may even increase it (caffeine?) Cholesterol some indication that green tea may reduce total and LDL cholesterol FMD Ras et al (2011) meta-analysis of intervention studies investigating tea and endothelial function. FMD 2.6% greater with 500ml/d of tea compared to placebo.

Taubert et al Tea and BP RCTs

Ras 2011 Tea and FMD RCTs

Tea and CV Health: Longer term RCTs Hartley et al (2013) Systematic Review of RCTs of >3 months, duration. 11 studies -7 looked at the effects of green tea, and 4 at black tea. Green tea reduced total cholesterol, and BP. Black tea reduced LDL cholesterol and BP. Black Tea LDL Black Tea SBP BUT only 2 studies for both black & green tea

Cardiovascular Health Cocoa Analysis of 7 countries/zutphen studies suggested cocoa/chocolate may be associated with reduced CV disease risk Several recent reports of potentially beneficial effects (RCTs) of acute and chronic cocoa flavanol intake, from high flavanol cocoa drinks, on BP and endothelial function

Taubert et al Cocoa and BP RCTs

Flavonoids and type 2 DM Balzer et al, JACC 2008 (Balzer et al, 2008) 963mg 963mg Entry Baseline Dose 963mg 30 days 371mg 75mg 75mg Reduction in LDL, no change in BP at 30 days

Cognitive function, BP and cocoa flavanols in elderly subjects (CoCoA study) Desideri et al 2012 3 group of 30 elderly subjects (71yr) with MCI received low (45mg), medium (520mg) or high (990mg) doses of CF daily for 8 weeks Cognitive function (MMSE, Trails A and B, verbal fluency), BP measured and blood samples taken for insulin, glucose, lipids. Saw cognitive improvements (partly dose related), reduction in BP and Insulin Resistance estimates. Latter was associated statistically with the cognitive changes

Milk and BP Livingstone KM, Lovegrove JA, Cockcroft JR, Elwood PC, Pickering JE Hypertension. 2013 in the highest group of milk consumption systolic blood pressure was 10.4 mm Hg lower (P trend=0.033) than in non-milk consumers after a 22.8-year follow-up

Cardiovascular Health Red wine Vidavalur et al (2006) - systematic review of wine and CVD risk. Wine drinkers had higher HDL and ApoA1 and lower lipoprotein(a) than non-drinkers. Moderate red wine consumption was associated with reduced platelet aggregation, (possibly due to reduced prostanoid synthesis) reduced fibrinogen, and increased fibrinolytic activity. Some of the CVD benefits may be due to red wine increasing NO dependant signalling.

Cardiovascular Health Red wine Chiva-Blanch et al (2013) - evidence relating red wine consumption and CVD. Stated that: Clear that heavy alcohol consumption is associated with increased mortality and morbidity. Moderate alcohol intake, especially drinks high in polyphenols, confer CVD protective effects, both in healthy volunteers and those with high CVD risk. However, most of these effects/associations are weak and not consistent across groups of subjects Overall the evidence for CV Health benefits is not convincing

Conclusions Some reasonable evidence of potential benefits for CV Health in relation to tea intake Whether there are major differences between green and black tea remain to be determined, and the confounding from ethnic/lifestyle differences in relation to tea consumption need to be resolved Whether any effect of tea is due to the flavanoids remains to be confirmed, but if this is the case then other beverage sources of flavanoids (Cocoa, Orange Juice) may also be of interest and the current level of research into effects of cocoa flavanols may generate some important findings